Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease
- PMID: 27062261
- PMCID: PMC4835512
- DOI: 10.1007/s00401-016-1571-z
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease
Abstract
Vascular dementia (VaD) is recognised as a neurocognitive disorder, which is explained by numerous vascular causes in the general absence of other pathologies. The heterogeneity of cerebrovascular disease makes it challenging to elucidate the neuropathological substrates and mechanisms of VaD as well as vascular cognitive impairment (VCI). Consensus and accurate diagnosis of VaD relies on wide-ranging clinical, neuropsychometric and neuroimaging measures with subsequent pathological confirmation. Pathological diagnosis of suspected clinical VaD requires adequate postmortem brain sampling and rigorous assessment methods to identify important substrates. Factors that define the subtypes of VaD include the nature and extent of vascular pathologies, degree of involvement of extra and intracranial vessels and the anatomical location of tissue changes. Atherosclerotic and cardioembolic diseases appear the most common substrates of vascular brain injury or infarction. Small vessel disease characterised by arteriolosclerosis and lacunar infarcts also causes cortical and subcortical microinfarcts, which appear to be the most robust substrates of cognitive impairment. Diffuse WM changes with loss of myelin and axonal abnormalities are common to almost all subtypes of VaD. Medial temporal lobe and hippocampal atrophy accompanied by variable hippocampal sclerosis are also features of VaD as they are of Alzheimer's disease. Recent observations suggest that there is a vascular basis for neuronal atrophy in both the temporal and frontal lobes in VaD that is entirely independent of any Alzheimer pathology. Further knowledge on specific neuronal and dendro-synaptic changes in key regions resulting in executive dysfunction and other cognitive deficits, which define VCI and VaD, needs to be gathered. Hereditary arteriopathies such as cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy or CADASIL have provided insights into the mechanisms of dementia associated with cerebral small vessel disease. Greater understanding of the neurochemical and molecular investigations is needed to better define microvascular disease and vascular substrates of dementia. The investigation of relevant animal models would be valuable in exploring the pathogenesis as well as prevention of the vascular causes of cognitive impairment.
Keywords: Alzheimer’s disease; Cerebral amyloid angiopathy; Cerebrovascular degeneration; Dementia; Neuropathology; Small vessel disease; Vascular dementia.
Figures






Similar articles
-
The pathology and pathophysiology of vascular dementia.Neuropharmacology. 2018 May 15;134(Pt B):226-239. doi: 10.1016/j.neuropharm.2017.12.030. Epub 2017 Dec 19. Neuropharmacology. 2018. PMID: 29273521 Review.
-
Stroke, cerebrovascular diseases and vascular cognitive impairment in Africa.Brain Res Bull. 2019 Feb;145:97-108. doi: 10.1016/j.brainresbull.2018.05.018. Epub 2018 May 25. Brain Res Bull. 2019. PMID: 29807146 Free PMC article. Review.
-
Stroke injury, cognitive impairment and vascular dementia.Biochim Biophys Acta. 2016 May;1862(5):915-25. doi: 10.1016/j.bbadis.2016.01.015. Epub 2016 Jan 22. Biochim Biophys Acta. 2016. PMID: 26806700 Free PMC article. Review.
-
Pathology and pathophysiology of vascular cognitive impairment. A critical update.Panminerva Med. 2004 Dec;46(4):217-26. Panminerva Med. 2004. PMID: 15876978 Review.
-
Pathology and pathogenesis of vascular cognitive impairment-a critical update.Front Aging Neurosci. 2013 Apr 10;5:17. doi: 10.3389/fnagi.2013.00017. eCollection 2013. Front Aging Neurosci. 2013. PMID: 23596414 Free PMC article.
Cited by
-
The Effect of Computer-Assisted Cognitive Remediation Therapy on Cognitive Function, Social Function and Quality of Life in Patients with Vascular Dementia.J Multidiscip Healthc. 2022 Oct 27;15:2473-2479. doi: 10.2147/JMDH.S378079. eCollection 2022. J Multidiscip Healthc. 2022. PMID: 36324875 Free PMC article.
-
Diagnostic Values of Advanced Glycation End Products and Homocysteine in Patients with Alzheimer's Disease and Sarcopenia.Comput Math Methods Med. 2022 Sep 9;2022:8949048. doi: 10.1155/2022/8949048. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Dec 13;2023:9786485. doi: 10.1155/2023/9786485. PMID: 36118832 Free PMC article. Retracted.
-
Postmortem 7T MRI for guided histopathology and evaluation of cerebrovascular disease.J Neuropathol Exp Neurol. 2022 Dec 19;82(1):57-70. doi: 10.1093/jnen/nlac103. J Neuropathol Exp Neurol. 2022. PMID: 36343095 Free PMC article.
-
Connexin43 promotes angiogenesis through activating the HIF-1α/VEGF signaling pathway under chronic cerebral hypoperfusion.J Cereb Blood Flow Metab. 2021 Oct;41(10):2656-2675. doi: 10.1177/0271678X211010354. Epub 2021 Apr 25. J Cereb Blood Flow Metab. 2021. PMID: 33899559 Free PMC article.
-
Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.J Alzheimers Dis. 2023;92(3):1037-1049. doi: 10.3233/JAD-230022. J Alzheimers Dis. 2023. PMID: 36847012 Free PMC article.
References
-
- Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, Kondo N, Sato T, Nakazawa H, Yamada T, Okada H, Yamamoto T, Kosaka K. Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci. 2002;196:63–69. - PubMed
-
- Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovacs GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H. Staging of neurofibrillary pathology in Alzheimer’s disease: a study of the BrainNet Europe Consortium. Brain Pathol. 2008;18:484–496. - PMC - PubMed
-
- Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Hoftberger R, Ironside JW, Jellinger K, Kavantzas N, King A, Korkolopoulou P, Kovacs GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB, Kretzschmar H. The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium. Exp Gerontol. 2012;47:825–833. - PubMed
-
- Altaf N, Daniels L, Morgan PS, Lowe J, Gladman J, MacSweeney ST, Moody A, Auer DP. Cerebral white matter hyperintense lesions are associated with unstable carotid plaques. Eur J Vasc Endovasc Surg. 2006;31:8–13. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources